- Gairdner Foundation presents a free public forum on Advances and
Opportunities in Cancer Prevention on Wednesday, Oct. 24th at the
University of Toronto.
- World's top cancer researchers discuss our increasing understanding
of how cancer can be prevented.
TORONTO, Oct. 5 /CNW/ - The Gairdner Foundation (www.gairdner.org) is
bringing eight of the world's most respected scientists in cancer prevention
to Toronto to discuss their work, including the opportunities and the
limitations for preventing cancer. The Gairdner Foundation is partnering in
this initiative with Cancer Care Ontario, the Ontario Division of the Canadian
Cancer Society and the National Cancer Institute of Canada.
All of these scientists will speak at a day-long Cancer Prevention Forum
that is free and open to the public on Wednesday, October 24th, from 8:30 a.m.
to 4:15 p.m. in the Main Auditorium, Department of Public Health Sciences,
University of Toronto, 155 College Street.
Said Gairdner President, Dr. John Dirks: "Part of our mandate is to
demonstrate the importance of medical research in all our lives and I can't
think of a subject more relevant and compelling than how research can prevent
Among the speakers are Sir Richard Peto from Oxford University, who first
proved the link between smoking and cancer and who will discuss "Cancer
mortality trends attributed to and not attributed to tobacco," and Dr. Douglas
Lowy from the National Institutes of Health in Bethesda, whose work led to the
creation of the HPV vaccine to prevent cervical cancer.
A full list of speakers and subjects is attached.
The Cancer Forum takes place the day before the Gairdner Gala Banquet, on
October 25th, when the 2007 Gairdner Awards ("The Gairdners") will be
presented to five international scientists for their fundamental discoveries
that will have an impact on genetic development, cancer and many other
The Cancer Forum is made possible through a contribution to the Gairdner
Foundation by Merck Frosst Canada Ltd.
The Gairdners (www.gairdner.org) are Canada's top biomedical prize. Now
in their 48th year, they have grown to be one of the most prestigious awards
in all of science, recognizing outstanding contributions by medical scientists
world wide, whose work will significantly improve the quality of life. Of the
283 Gairdner awardees, 68 have gone on to win the Nobel Prize.
Since 2003, the Canadian Institutes for Health Research (CIHR) has been
the national sponsor of the Gairdner Awards. CIHR is the major federal agency
responsible for funding health research in Canada, supporting the work of
10,000 researchers in universities, teaching hospitals and research institutes
across Canada. The results are improved health for Canadians, more effective
health services and products and a strengthened Canadian health care system.
The Gairdner Foundation in partnership with
CCS (Ontario Division) - NCIC and CCO present
Advances and Opportunities in Cancer Prevention:
A Cancer Prevention Forum
Wednesday, October 24, 8:30am - 4:15pm
Main Auditorium, Department of Public Health Sciences
University of Toronto, 155 College Street, Room HS610 (6th floor)
Admission is free
8:30 Opening remarks - John Dirks (Gairdner Foundation),
Terry Sullivan (CCO),
Peter Goodhand (CCS)
Risk Factors and their Modifiability
8:45 Dr. Richard Peto, Oxford University, Oxford
Treatment of early breast cancer and halving premature death
9:30 Dr. Salim Yusef, McMaster University, Hamilton
Can we prevent the majority of CVD in the foreseeable future by
targeting risk factors?
Cancer Genetics and Prevention in High Risk Populations
10:30 Dr. Bruce Ponder, Cambridge Research Institute, Cambridge
Breast cancer susceptibility and control
11:15 Dr. Steve Gallinger, Samuel Lunenfeld Research Inst. & Mount
Sinai Hospital, Toronto
Genome-wide association studies in colorectal cancer
Infection and Vaccination in Cancer Prevention
12:45 Dr. Lorne Tyrrell, University of Alberta, Edmonton
Hepatitis B vaccine and prevention of liver cancer
1:30 Dr. Douglas Lowy, National Institutes of Health, Bethesda,
HPV vaccine and the prevention of cervical cancer
2:15 Dr. George Pasut, Chief Medical Officer of Health (A) for
HPV Vaccination in Ontario - The Path from Scientific Promise to
Public Health Impact
Applying Current Knowledge for Cancer Prevention
3:15 Dr. Graham Colditz, Washington University, St Louis
Translating research to practice: strategies and priorities for
4:00 Closing remarks Dr. John McLaughlin, CCO and the Samuel
Lunenfeld Research Inst.
Made possible through a contribution to the Gairdner Foundation by
Merck Frosst Canada Ltd.
For further information:
For further information: Bob Ramsay, (416) 598-3970, email@example.com